Immunology

Immunology includes companies working on autoimmune disease, inflammation, allergy, and immune-modulating therapies. This sector page brings together names focused on controlling overactive immune pathways or restoring immune balance across chronic inflammatory disorders.

Why watch Immunology

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Immunology news

The latest feed items from companies currently grouped under Immunology.

1. 01
   2026-09-20 10:00 EST

   CUECue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria

   Source: Cue Biopharma Inc

2. 02
   2026-09-17 20:03 EST

   ARGXargenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors

   Source: Argenx

3. 03
   2026-09-17 11:00 EST

   TLSATiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center

   Source: Tiziana Life Sciences

4. 04
   2026-09-16 12:30 EST

   EQEquillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum

   Source: Equillium, Inc.

5. 05
   2026-09-15 10:30 EST

   VERAVera Therapeutics Announces TRUTAKNA™ (atacicept-vymj) Stabilized eGFR and Prevented Kidney Disease Progression Through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy

   Source: Vera Therapeutics

6. 06
   2026-09-14 11:00 EST

   INMBINmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board

   Source: INmune Bio

7. 07
   2026-09-14 08:00 EST

   BNTXNeue Daten zu Gotistobart zeigten annähernde Verdopplung des medianen Gesamtüberlebens im Vergleich zur Standardchemotherapie bei Patientinnen und Patienten mit zuvor behandeltem Plattenepithelkarzinom der Lunge

   Source: BioNTech

8. 08
   2026-09-14 08:00 EST

   BNTXBioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients

   Source: BioNTech

9. 09
   2026-09-11 12:00 EST

   IMMPImmutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)

   Source: Immutep Limited

10. 10
    2026-09-09 12:00 EST

    INMBINmune Bio to Present at the H.C. Wainwright Global Investment Conference

    Source: INmune Bio

11. 11
    2026-09-09 11:00 EST

    ELDNEledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society

    Source: Eledon Pharmaceuticals, Inc.

12. 12
    2026-09-09 11:00 EST

    XFORX4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference

    Source: X4 Pharmaceuticals

13. 13
    2026-09-08 20:01 EST

    CLDXCelldex to Present at Upcoming Investor Conference

    Source: Celldex Therapeutics

14. 14
    2026-09-08 13:15 EST

    GRIGRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

    Source: GRI Bio

15. 15
    2026-09-08 12:50 EST

    HCWBHCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells

    Source: HCW Biologics

16. 16
    2026-09-08 12:00 EST

    GPCRStructure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

    Source: Structure Therapeutics

17. 17
    2026-09-08 12:00 EST

    SYRESpyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations

    Source: Spyre Therapeutics, Inc.

18. 18
    2026-09-08 11:00 EST

    RNACCartesian Therapeutics Announces New Employment Inducement Grants

    Source: Cartesian Therapeutics

19. 19
    2026-09-08 11:00 EST

    XFORX4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting

    Source: X4 Pharmaceuticals

20. 20
    2026-09-08 10:59 EST

    BMYBristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 QUINTESSENTIAL Trial of the Potential First-in-Class GPRC5D-Directed CAR T Cell Therapy, Arlocabtagene Autoleucel ...

    Source: BMYBristol-Myers Squibb Company

Companies in Immunology

95 companies tagged with Immunology.

Frequently Asked Questions